Pancreatic Cancer Incidence, Mortality, and Survival in Puerto Rico, 2001–2015
Vol. 38 No. 3 (2019), Full-Length Articles
Vol. 38 No. 3 (2019)

Pancreatic Cancer Incidence, Mortality, and Survival in Puerto Rico, 2001–2015

Full-Length Articles
Published 2019-09-10
  • Castañeda-Avila M+−
  • Torres-Cintrón CR
  • Cruz-Benítez A
  • Fuentes-Payán W
  • Maldonado-Albertorio A
  • Nieves-Ferrer L
  • Padró-Juarbe P
  • Soto-Abreu R
  • Perez-Ríos N
  • Ortiz-Ortiz KJ
  • Magno P
  • Ortiz AP
Castañeda-Avila M
PhD
Torres-Cintrón CR
Cruz-Benítez A
Fuentes-Payán W
Maldonado-Albertorio A
Nieves-Ferrer L
Padró-Juarbe P
Soto-Abreu R
Perez-Ríos N
Ortiz-Ortiz KJ
Magno P
Ortiz AP
PDF

Keywords

Pancreatic cancer
incidence
mortality

How to Cite

M, C.-A., CR, T.-C., A, C.-B., W, F.-P., A, M.-A., L, N.-F., … AP, O. (2019). Pancreatic Cancer Incidence, Mortality, and Survival in Puerto Rico, 2001–2015. Puerto Rico Health Sciences Journal, 38(3). Retrieved from https://prhsj.rcm.upr.edu/index.php/prhsj/article/view/1723
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Objective: To perform an epidemiologic profile of pancreatic cancer (PC) in Puerto Rico (PR) with data gathered from 2001 to 2015. Methods: Using data from the PR Central Cancer Registry we estimated incidence and mortality rates and trends of PC in PR, and performed survival analyses. We also compared the age-standardized incidence and mortality rates of PC in people in PR with those of Hispanics, non-Hispanic whites, and non Hispanic blacks in the United States (US). Results: From 2011 to 2015, 7.8 per 100,000 persons were diagnosed with PC in PR; higher rates were observed in men than in women (9.2 vs. 6.7 per 100,000, respectively) and in persons 65 years old and older (42.7 per 100,000 persons). For the same period, 6.7 per 100,000 persons died from PC; men and persons 65 years and older had higher mortality rates. Incidence and mortality trends of PC in PR increased from 2001-2015 (annual percent change [APC] = 3.8% and 1.9%, respectively (p<0.05). Lower risk of being diagnosed with and dying from PC was seen in PR than in members of several racial/ethnic groups in the US. The median survival time for PC cases diagnosed in PR during the period of 2008 to 2012 was 5.3 months. Conclusion: We observed increasing mortality rates and low survival in PC patients in PR. Research on access and response to treatment is needed to elucidate the reasons for the observed results and have a positive impact on PC burden and survival.
PDF
Authors who publish with this journal agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).